DPP8/9-IN-2
DPP8/9-IN-2 (Compound 21) is a DPP8/9 inhibitor with IC50 values of 0.22 nM and 3 nM, respectively, and Ki values of 2.9 nM and 6 nM, respectively . DPP8/9-IN-2 has certain cardiotoxicity, with IC50 values of 0.7 μM, 29.0 μM and 27.7 μM for hERG potassium channel, Nav1.5 sodium channel and Cav1.2 calcium channel, respectively. DPP8/9-IN-2 can be used in the research of diseases such as tumors[1].
Product Specifications
UNSPSC
12352005
Target
Calcium Channel; Dipeptidyl Peptidase; Potassium Channel; Sodium Channel
Related Pathways
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(N1CC2=C(C=C(F)C=C2)C1)[C@@H](N)CC(N3CCC(C(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5)CC3)=O
Molecular Formula
C30H30F3N3O2
Molecular Weight
521.57
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DPP-8; DPP-9; Nav1.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PTPN14 (Protein Tyrosine Phosphatase, non-Receptor Type 14, MGC126803, PEZ, PTP36) (MaxLight 750) discontinued
